A U.S. Food and Drug Administration
advisory panel on Tuesday voted against a therapy based on the
party drug MDMA for patients with post-traumatic stress
disorder, marking a setback to the nascent. -June 04, 2024 at 05:39 pm EDT
- MarketScreener
By Sriparna Roy and Pratik Jain (Reuters) - A panel of advisers to the U.S. Food and Drug Administration will meet on Tuesday to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder (PTSD). The meet.
May GST collection grows 10% y-o-y to ₹1 73 lakh crore hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
US FDA staff flags concerns on MDMA-assisted PTSD treatment yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.